Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Substances“
Suchtreffer
Begriffe & Kennungen
Autacoide
Eintrag öffnenAwiqli · 4.5 · The following substances may increase the insulin requirement
Eintrag öffnenAzarga · 4.3 · • Hypersensitivity to the active substances or to any of the excipients listed in section 6.1. • Hypersensitiv
Eintrag öffnenBeromun · 4.3 · Patients with contraindications to the use of vasopressor substances.
Eintrag öffnenBeromun · 4.3 · Simultaneous treatment with cardiotoxic substances (e.g. anthracyclines).
Eintrag öffnenBeromun · 4.5 · Combinations with cardiotoxic substances (e.g. anthracyclines) should be avoided because it is possible that t
Eintrag öffnenBetmiga · 4.5 · Effect of enzyme inducers Substances that are inducers of CYP3A or P-gp decrease the plasma concentrations of
Eintrag öffnenBetmiga · 4.5 · Effect of enzyme inducers Substances that are inducers of CYP3A or P-gp decrease the plasma concentrations of
Eintrag öffnenBexsero · 4.3 · Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
Eintrag öffnenBiktarvy · 4.3 · Hypersensitivity to the active substances or to any of the excipients listed in section 6.1.
Eintrag öffnenBondronat · 4.5 · Caution is advised when bisphosphonates are administered with aminoglycosides, since both substances can lower
Eintrag öffnenBondronat · 4.5 · Caution is advised when bisphosphonates are administered with aminoglycosides, since both substances can lower
Eintrag öffnenBosulif · 4.5 · Anti-arrhythmic medicinal products and other substances that may prolong QT Bosutinib should be used with caut
Eintrag öffnenBrilique · 4.5 · No data are available on concomitant use of ticagrelor with other active substances that also are potent P-gp
Eintrag öffnenBrilique · 4.5 · No data are available on concomitant use of ticagrelor with other active substances that also are potent P-gp
Eintrag öffnenBrilique · 4.5 · No data are available on concomitant use of ticagrelor with other active substances that also are potent P-gp
Eintrag öffnenBulk Drugs
Eintrag öffnenCalquence · 4.5 · Active substances that may decrease acalabrutinib plasma concentrations
Eintrag öffnenCalquence · 4.5 · Active substances that may decrease acalabrutinib plasma concentrations
Eintrag öffnenCalquence · 4.5 · Active substances that may increase acalabrutinib plasma concentrations
Eintrag öffnen